Advertisement

Topics

ReNeuron Outlines First-To-Market Plans For Stroke Disability Cell Therapy

07:34 EDT 29 Jun 2017 | SCRIP

ReNeuron has high hopes of being the first to reach the US market with a novel stem cell therapy for...

      

Related Stories

 

Original Article: ReNeuron Outlines First-To-Market Plans For Stroke Disability Cell Therapy

NEXT ARTICLE

More From BioPortfolio on "ReNeuron Outlines First-To-Market Plans For Stroke Disability Cell Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...